Researchers at Greater Manchester Mental Health NHS Foundation Trust and the Northern Care Alliance, working with colleagues in the Geoffrey Jefferson Brain Research Centre and international collaborators in Spain and Italy have found that people with both cognitive impairment and chronic kidney disease (CKD) had worse health outcomes than people with CKD alone.

The clinical investigation study was conducted at Salford Royal Hospital, part of Northern Care Alliance NHS Foundation Trust in Manchester, UK. The study was led by Chief Clinical Investigator Dr David Coope, a neurosurgeon at the Manchester Centre for Clinical Neuroscience and Brain Tumours Theme Lead at the Geoffrey Jefferson Brain Research Centre, and Chief Scientific Investigator Kostas Kostarelos, PhD, Professor of Nanomedicine at The University of Manchester, the Catalan Institute of Nanoscience & Nanotechnology, and Co-Founder of INBRAIN.